Annual report pursuant to Section 13 and 15(d)

Intangible Asset, Net - Additional Information (Details)

v3.25.0.1
Intangible Asset, Net - Additional Information (Details) - Pfizer License Agreement - USD ($)
$ in Millions
Oct. 25, 2024
Nov. 18, 2015
Intangible Assets Net Excluding Goodwill [Line Items]    
Regulatory milestone payments upon approval of product   $ 20.0
Regulatory milestone payment amortization period 14 years 4 months 24 days